NRXS
Price
$6.25
Change
-$0.03 (-0.48%)
Updated
Jul 31 closing price
Capitalization
77.98M
45 days until earnings call
Intraday BUY SELL Signals
PMVP
Price
$1.11
Change
-$0.02 (-1.77%)
Updated
Jul 31 closing price
Capitalization
59.2M
3 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRXS vs PMVP

NRXS vs PMVP Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NRXS vs. PMVP commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRXS is a Hold and PMVP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (NRXS: $6.25 vs. PMVP: $1.11)
Brand notoriety: NRXS and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRXS: 44% vs. PMVP: 32%
Market capitalization -- NRXS: $77.98M vs. PMVP: $59.2M
NRXS [@Biotechnology] is valued at $77.98M. PMVP’s [@Biotechnology] market capitalization is $59.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRXS’s FA Score shows that 0 FA rating(s) are green whilePMVP’s FA Score has 0 green FA rating(s).

  • NRXS’s FA Score: 0 green, 5 red.
  • PMVP’s FA Score: 0 green, 5 red.
According to our system of comparison, NRXS is a better buy in the long-term than PMVP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRXS’s TA Score shows that 5 TA indicator(s) are bullish while PMVP’s TA Score has 5 bullish TA indicator(s).

  • NRXS’s TA Score: 5 bullish, 3 bearish.
  • PMVP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, NRXS is a better buy in the short-term than PMVP.

Price Growth

NRXS (@Biotechnology) experienced а -8.09% price change this week, while PMVP (@Biotechnology) price change was -10.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +2790.29%.

Reported Earning Dates

NRXS is expected to report earnings on Sep 17, 2026.

PMVP is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRXS($78M) has a higher market cap than PMVP($59.2M). NRXS YTD gains are higher at: 37.665 vs. PMVP (-11.200). NRXS has higher annual earnings (EBITDA): -7.12M vs. PMVP (-83.53M). PMVP has more cash in the bank: 93.5M vs. NRXS (7.08M). PMVP has less debt than NRXS: PMVP (293K) vs NRXS (354K). NRXS has higher revenues than PMVP: NRXS (4.28M) vs PMVP (0).
NRXSPMVPNRXS / PMVP
Capitalization78M59.2M132%
EBITDA-7.12M-83.53M9%
Gain YTD37.665-11.200-336%
P/E RatioN/AN/A-
Revenue4.28M0-
Total Cash7.08M93.5M8%
Total Debt354K293K121%
FUNDAMENTALS RATINGS
PMVP: Fundamental Ratings
PMVP
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
1

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRXSPMVP
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 13 days ago
86%
Bullish Trend 12 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
NRXS
Daily Signal:
Gain/Loss:
PMVP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WOFNX67.060.69
+1.04%
Allspring Opportunity Inst
LIORX15.49-0.05
-0.32%
ClearBridge International Value R
LMGNX75.15-0.35
-0.46%
ClearBridge International Growth I
MSCYX15.30-0.10
-0.65%
MassMutual Small Cap Gr Eq Svc
MSJAX22.32-0.23
-1.02%
Morgan Stanley Global Endurance A

NRXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXS has been loosely correlated with CVM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if NRXS jumps, then CVM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
-0.48%
CVM - NRXS
58%
Loosely correlated
-4.92%
ANRO - NRXS
29%
Poorly correlated
-5.45%
PVLA - NRXS
28%
Poorly correlated
-7.42%
NTLA - NRXS
27%
Poorly correlated
-3.70%
PMVP - NRXS
27%
Poorly correlated
-1.77%
More

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with CLLS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
-1.77%
CLLS - PMVP
39%
Loosely correlated
-3.51%
MTVA - PMVP
35%
Loosely correlated
-1.39%
AXON - PMVP
31%
Poorly correlated
+0.47%
ARRY - PMVP
31%
Poorly correlated
+2.76%
VCYT - PMVP
30%
Poorly correlated
-22.52%
More